Effective models need to be developed to ensure case identification in vulnerable settings and among vulnerable populations that can lead to effective treatment and efficient hepatitis C virus (HCV) prevention, a new study suggests. The cross-sectional study between May 2011 and June 2013 sought to estimate the prevalence of HCV in vulnerable populations that included homelessness, people who inject drugs (PWID), and prisoners. A questionnaire was administered and blood sample were tested for HCV. Among the details:
- 491 individuals who were homeless (40.7%), 205 drug users (17%), and 511 prisoners (42.3%) were recruited.
- Overall, one-quarter of those recruited in drug treatment services, 13% of those from homeless residential sites, and 4% of prisoners were anti-HCV positive.
- 56.6% of HCV-infected participants identified had a history of all 3 risk factors, 27.3% had 2 overlapping risk factors, and 15.4% had 1 risk factor.
Aisyah DN, Shallcross L, Hayward A, et al. Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs, and prisoners in London. [Published online ahead of print May 31, 2018]. J Viral Hepat. doi:10.1111/jvh.12936.
This Week's Must Reads
Must Reads in Hepatitis
Glecaprevir/Pibrentasvir Efficacy & Safety Assessed, J Hepatol; ePub 2018 Nov 23; D’Ambrosio, et al
HCV Infection Among Children & Young Persons, J Hepatol; ePub 2018 Nov 26; Modin, et al
HCV Patients with Limited Access to Antiviral Therapy, Dig Liver Dis; ePub 2018 Nov 29; Lens, et al
Progression in the Elimination of HCV Infection, PLoS One; ePub 2018 Dec 4; Juanbeltz, et al
Increased HCV Screening in Veteran Populations, Jt Comm J Qual Patient Saf; ePub 2018 Sep 25; Wray, et al